Plagiarism Screening

Applied Pharmacology and Pharmaceutical Technology (APPT)

To uphold academic integrity and ensure the originality of all published manuscripts, the Applied Pharmacology and Pharmaceutical Technology (APPT) implements a strict plagiarism screening policy.

All manuscripts submitted to APPT are subjected to plagiarism detection using the Turnitin software prior to the peer review process. The editorial office carefully examines each similarity report to ensure that submitted works are original and properly cited.

Screening Criteria

  • A manuscript is considered acceptable if the overall similarity index is 25% or below, as indicated by the Turnitin report.

  • Similarity originating from references, direct quotations, and commonly used terminologies is generally excluded from the calculation, provided they are properly cited.

  • Manuscripts exceeding 25% similarity will be returned to the author for revision or rejected outright, depending on the extent and nature of the duplication.

  • Repeated submission of plagiarized content may result in blacklisting of the author from future submissions.

Author Responsibility

Authors are strongly advised to check their manuscripts for plagiarism before submission using recognized similarity detection software. Proper citation and paraphrasing must be practiced to avoid academic misconduct.

Authors must ensure that all data, figures, and text presented are original or properly attributed to their sources. Any re-use of previously published material (including by the same author) must be explicitly stated and appropriately cited.

Editorial and Ethical Considerations

The editorial team reserves the right to re-screen accepted manuscripts at any stage of the publication process. If plagiarism is detected after publication, the article may be retracted following the COPE Retraction Guidelines, and a notice of retraction will be publicly issued.

The journal strictly follows the ethical principles outlined by the Committee on Publication Ethics (COPE) to handle cases of suspected plagiarism and research misconduct.